Paolo Pucci

Mr. Paolo Pucci is an Independent Director at Tarus Therapeutics, Inc., an Independent Director at Replimune Group, Inc. and a Lead Independent Director at West Pharmaceutical Services, Inc. He is on the Board of Directors at Tarus Therapeutics, Inc., Replimune Group, Inc. and West Pharmaceutical Services, Inc. Mr. Pucci was previously employed as a Lead Independent Director by Trillium Therapeutics, Inc., an Independent Non-Executive Director by Merus NV, an Independent Director by NewLink Genetics Corp., a Non-Executive Director by Algeta ASA, an Independent Director by Dyax Corp., a Chief Executive Officer by ArQule, Inc., a President-Oncology & Global Specialty Medicines by Bayer AG, a Senior Vice President by Bayer Pharma AG, a President-US Pharmaceutical Operations by Bayer Pharmaceuticals Corp., and a Managing Director by Eli Lilly Sweden AB. He received his undergraduate degree from Università degli Studi di Napoli Federico II and an MBA from The University of Chicago Booth School of Business.